NCT02505126View on ClinicalTrials.gov

A Clinical Trial on the Efficacy of tDCS) in Reducing Alcohol Consumption in Non-abstinent Patients (REDSTIM)

NACompletedINTERVENTIONAL

Enrollment

339

Participants

Timeline

Start Date

November 23, 2015

Primary Completion Date

December 23, 2021

Study Completion Date

December 23, 2021

Conditions

Alcoholic Intoxication, Chronic

Interventions

DEVICE

Active tDCS

One daily session (13:20:13) : active current flows continuously twice for 13 minutes with a rest interval (no stimulation) of 20 min 5 sessions (once a week for 5 consecutive days)

DEVICE

Placebo tDCS

One daily session (13:20:13) : inactive current flows continuously twice for 13 with a rest interval (no stimulation) of 20 min 5 sessions (once a week for 5 consecutive days)

Trial Locations (1)

21079

CHU de DIJON, Dijon

All Listed Sponsors

lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT02505126 - A Clinical Trial on the Efficacy of tDCS) in Reducing Alcohol Consumption in Non-abstinent Patients (REDSTIM) | Biotech Hunter | Biotech Hunter